Dimensional Fund Advisors
EPRS

Dimensional Fund Advisors’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Dimensional Fund Advisors’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,229
Closed -$18K – 3548
2014
Q4 		$18K Hold
3,229
– – ﹤0.01% 3430
2014
Q3 		$23K Buy
+3,229
New +$27.9K ﹤0.01% 3439

Other funds holding EPRS

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Dimensional Fund Advisors's EPRS Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q1 2015, closing a stake of 3,229 shares — an estimated $18K sold.

Dimensional Fund Advisors first reported a position in EPRS in Q3 2014 and held it in 2 quarters. The position peaked at $23K in Q3 2014. 47 funds tracked by Wall St. Rank hold EPRS as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 3,229 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q1 2015, an estimated $18K.
  • Dimensional Fund Advisors first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 2 quarters.
  • Dimensional Fund Advisors's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $23K in Q3 2014.
  • 47 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.